Research loss in Pfizer-Wyeth deal

Pfizer's $68 billion merger with Wyeth, which officially linkurl:commences today,;http://www.pfizer.com/news/press_releases/pfizer_press_releases.jsp?rssUrl=http://mediaroom.pfizer.com/portal/site/pfizer/index.jsp?ndmViewId=news_view&ndmConfigId=1016273&newsId=20091015006478&newsLang=en will mean the loss of almost 20,000 jobs, the company has said, and analysts predict research could take a hard hit. The deal involves combining laboratories of the once-competing companies. Martin Mackay, pres

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Pfizer's $68 billion merger with Wyeth, which officially linkurl:commences today,;http://www.pfizer.com/news/press_releases/pfizer_press_releases.jsp?rssUrl=http://mediaroom.pfizer.com/portal/site/pfizer/index.jsp?ndmViewId=news_view&ndmConfigId=1016273&newsId=20091015006478&newsLang=en will mean the loss of almost 20,000 jobs, the company has said, and analysts predict research could take a hard hit. The deal involves combining laboratories of the once-competing companies. Martin Mackay, president of Pfizer Global Research and Development, linkurl:told Bloomberg News;http://www.bloomberg.com/apps/news?pid=20601103&sid=aAh8pjthSok8 that the merger would likely involve cuts in research spending. Though he didn't specify how much, analyst estimates put the number at as much as $3 billion, Bloomberg News reports -- which will translate into job losses. "These big acquisitions don't do a thing for research," linkurl:Kenneth Kaitin,;http://csdd.tufts.edu/About/ResearchStaff.asp director of the Tufts Center for the Study of Drug Development, told Bloomberg News. "I don't think anyone should be fooled into thinking these big acquisitions have anything to do with innovation or increased research and development capacity." As a result of the merger, many facilities will be shuttered. The Wall Street Journal Health Blog is linkurl:compiling reports;http://blogs.wsj.com/health/2009/10/16/pfizer-wyeth-which-sites-are-closing-which-are-staying-open/ on the fate of individual Wyeth and Pfizer locations.
**__Related stories:__***linkurl:Merck and Schering-Plough to merge;http://www.the-scientist.com/blog/display/55497/
[9th March 2009]*linkurl:How to save biotech;http://www.the-scientist.com/news/display/55425/
[17th February 2009]*linkurl:The urge to merge;http://www.the-scientist.com/article/display/14931/
[13th September 2004]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Alla Katsnelson

    This person does not yet have a bio.
Share
A greyscale image of cells dividing.
March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue
Discover the history, mechanics, and potential of PCR.

Become a PCR Pro

Integra Logo
3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Thermo Fisher Logo
A photo of sample storage boxes in an ultra-low temperature freezer.

Navigating Cold Storage Solutions

PHCbi logo 
The Immunology of the Brain

The Immunology of the Brain

Products

Sapio Sciences

Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo

DeNovix Logo

New DeNovix Helium Nano Volume Spectrophotometer

Olink Logo

Olink® Reveal: Accessible NGS-based proteomics for every lab

Olink logo
Zymo Logo

Zymo Research Launches the Quick-16S™ Full-Length Library Prep Kit